← Eichor
Study identifier: NCT07242625 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Pilot Study on Efficacy of Digital Therapeutic NDTx-02 for Executive Function in Children and Adolescents With ADHD or ASD

Condition: Attention-Deficit/Hyperactivity Disorder · Autism Spectrum Disorder  ·  Sponsor: Neudive Inc.

PhaseNA
Planned participants48
Who can joinAll sexes, 5 Years to 12 Years
Healthy volunteersNo

About this study

The purpose of this study is to explore the preliminary safety and effectiveness of the digital therapeutic device 'NDTx-02' in supporting improvements of executive function in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD).

This description comes directly from the study's public registry record.

Talk to the study team

SungJa Cho  ·  +82-2-6959-9933  ·  sungja_cho@neudive.com

Always discuss trial participation with your own doctor first.

Locations (3)

Daegu Catholic University Medical CenterDaegu, South KoreaRecruiting
Samsung Medical CenterSeoul, South KoreaRecruiting
The Catholic University of Korea, Seoul St. Mary's HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07242625